Experimental Hematology Group - VHIO

VHIO’s Experimental Hematology Group conducts translational, pre-clinical and clinical research on hematological neoplasms of both lymphoid and myeloid origin. Our research team is composed of hematologists and biological scientists who work closely together to design, conduct and lead our programs.

Gaël Roué

COVID-19 in adult acute myeloid leukemia patients: a long-term

Cristina HERNANDEZ PhD Student in Experimental Hematology Group

Experimental Hematology & Oncology

Home - VHIO

The FANCM:p.Arg658* truncating variant is associated with risk of

DMWC meeting at International Fashion Institute Izet Curi, October

Experimental Hematology & Oncology

PDF) Regulation of B-Cell Receptor Signaling and Its Therapeutic

VHIO consolidates its advanced therapy programme to develop new

PDF) Microenvironment regulates the expression of MIR-21 and tumor

Conservation of copy number profiles during engraftment and